{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:47:59Z","timestamp":1772704079350,"version":"3.50.1"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CEVA Sante Animale","award":["PO1126151"],"award-info":[{"award-number":["PO1126151"]}]},{"name":"CEVA Sante Animale","award":["PO1126151"],"award-info":[{"award-number":["PO1126151"]}]},{"name":"CEVA Sante Animale","award":["PO1126151"],"award-info":[{"award-number":["PO1126151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71202-y","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T02:03:18Z","timestamp":1725501798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preclinical modeling of metabolic syndrome to study the pleiotropic effects of novel antidiabetic therapy independent of obesity"],"prefix":"10.1038","volume":"14","author":[{"given":"Jonathan P.","family":"Mochel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Blondel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debosmita","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria M.","family":"Merodio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Zemirline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryland T.","family":"Giebelhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"de la Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea A.","family":"Iennarella-Servantez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Blong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seo Lin","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Harynuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Suchodolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asta","family":"Tvarijonaviciute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Joaqu\u00edn","family":"Cer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Bourgois-Mochel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Allenspach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"11","key":"71202_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","unstructured":"Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: The diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 3(11), 866\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(15)00291-0 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"71202_CR2","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report website. https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html. Accessed 09 Dec 2023."},{"issue":"4","key":"71202_CR3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/dom.13612","volume":"21","author":"KI Birkeland","year":"2019","unstructured":"Birkeland, K. I. et al. How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT-2 inhibitors? A large European observational study. Diabetes Obes. Metab. 21(4), 968\u2013974. https:\/\/doi.org\/10.1111\/dom.13612 (2019).","journal-title":"Diabetes Obes. Metab."},{"issue":"13","key":"71202_CR4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/eurheartj\/ehaa1007","volume":"42","author":"J Butler","year":"2021","unstructured":"Butler, J. et al. EMPEROR-reduced trial committees and investigators. Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: The EMPEROR-reduced trial. Eur. Heart J. 42(13), 1203\u20131212. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1007 (2021).","journal-title":"Eur. Heart J."},{"issue":"4","key":"71202_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/dom.13938","volume":"22","author":"SE Inzucchi","year":"2020","unstructured":"Inzucchi, S. E. et al. Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?. Diabetes Obes. Metab. 22(4), 631\u2013639. https:\/\/doi.org\/10.1111\/dom.13938 (2020).","journal-title":"Diabetes Obes. Metab."},{"issue":"12","key":"71202_CR6","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod, M. N. et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N. Engl. J. Med. 389(12), 1069\u20131084. https:\/\/doi.org\/10.1056\/NEJMoa2306963 (2023).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"71202_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/ejhf.1548","volume":"21","author":"JJV McMurray","year":"2019","unstructured":"McMurray, J. J. V. et al. The dapagliflozin and prevention of adverse-outcomes in heart failure (DAPA-HF) trial: Baseline characteristics. Eur. J. Heart Fail. 21(11), 1402\u20131411. https:\/\/doi.org\/10.1002\/ejhf.1548 (2019).","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"71202_CR8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal, B. et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N. Engl. J. Med. 377(7), 644\u2013657. https:\/\/doi.org\/10.1056\/NEJMoa1611925 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"71202_CR9","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/ejhf.2065","volume":"22","author":"M Packer","year":"2020","unstructured":"Packer, M. et al. Design of a prospective patient-level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure. Eur. J. Heart Fail. 22(12), 2393\u20132398. https:\/\/doi.org\/10.1002\/ejhf.2065 (2020).","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"71202_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/dom.13077","volume":"20","author":"F Persson","year":"2018","unstructured":"Persson, F. et al. Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study. Diabetes Obes. Metab. 20(2), 344\u2013351. https:\/\/doi.org\/10.1111\/dom.13077 (2018).","journal-title":"Diabetes Obes. Metab."},{"issue":"22","key":"71202_CR11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman, B. et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373(22), 2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720 (2015).","journal-title":"N. Engl. J. Med."},{"key":"71202_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001184","author":"CE Ndumele","year":"2023","unstructured":"Ndumele, C. E. et al. Cardiovascular-kidney-metabolic health: A presidential advisory from the American heart association. Circulation https:\/\/doi.org\/10.1161\/CIR.0000000000001184 (2023).","journal-title":"Circulation"},{"issue":"17","key":"71202_CR13","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy, S. M. et al. American heart association; national heart, lung, and blood institute diagnosis and management of the metabolic syndrome: An American heart association\/national heart, lung, and blood institute scientific statement. Circulation 112(17), 2735\u20132752. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.169404 (2005).","journal-title":"Circulation"},{"key":"71202_CR14","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jhep.2023.07.033","volume":"79","author":"PN Newsome","year":"2023","unstructured":"Newsome, P. N. & Ambery, P. Incretins (GLP-1 receptor agonists and dual\/triple agonists) and the liver. J. Hepatol. 79, 1557\u20131565. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.033 (2023).","journal-title":"J. Hepatol."},{"issue":"15","key":"71202_CR15","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jama.2016.0082","volume":"315","author":"JA Jacob","year":"2016","unstructured":"Jacob, J. A. Researchers turn to canine clinical trials to advance cancer therapies. JAMA 315(15), 1550\u20131552. https:\/\/doi.org\/10.1001\/jama.2016.0082 (2016) (PMID: 27027696).","journal-title":"JAMA"},{"issue":"9","key":"71202_CR16","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1073\/pnas.1222878110","volume":"110","author":"J Seok","year":"2013","unstructured":"Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 110(9), 3507\u20133512. https:\/\/doi.org\/10.1073\/pnas.1222878110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"71202_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","volume":"14","author":"MJ Waring","year":"2015","unstructured":"Waring, M. J. et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat. Rev. Drug Discov. 14(7), 475\u2013486. https:\/\/doi.org\/10.1038\/nrd4609 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"21","key":"71202_CR18","doi-asserted-by":"publisher","first-page":"e175824","DOI":"10.1172\/JCI175824","volume":"133","author":"PH Zushin","year":"2023","unstructured":"Zushin, P. H., Mukherjee, S. & Wu, J. C. FDA modernization act 2.0: Transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J. Clin. Invest. 133(21), e175824. https:\/\/doi.org\/10.1172\/JCI175824 (2023).","journal-title":"J. Clin. Invest."},{"key":"71202_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.exger.2015.08.008","volume":"71","author":"KM Gilmore","year":"2015","unstructured":"Gilmore, K. M. & Greer, K. A. Why is the dog an ideal model for aging research?. Exp. Gerontol. 71, 14\u201320. https:\/\/doi.org\/10.1016\/j.exger.2015.08.008 (2015) (Epub 2015 Aug 29 PMID: 26325590).","journal-title":"Exp. Gerontol."},{"issue":"10","key":"71202_CR20","doi-asserted-by":"publisher","first-page":"e1000161","DOI":"10.1371\/journal.pmed.1000161","volume":"6","author":"I Gordon","year":"2009","unstructured":"Gordon, I., Paoloni, M., Mazcko, C. & Khanna, C. The comparative oncology trials consortium: Using spontaneously occurring cancers in dogs to inform the cancer drug development pathway. PLoS Med. 6(10), e1000161. https:\/\/doi.org\/10.1371\/journal.pmed.1000161 (2009).","journal-title":"PLoS Med."},{"issue":"7\u20138","key":"71202_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00335-016-9638-7","volume":"27","author":"M Kaeberlein","year":"2016","unstructured":"Kaeberlein, M., Creevy, K. E. & Promislow, D. E. The dog aging project: Translational geroscience in companion animals. Mamm. Genome 27(7\u20138), 279\u2013288. https:\/\/doi.org\/10.1007\/s00335-016-9638-7 (2016).","journal-title":"Mamm. Genome"},{"issue":"3","key":"71202_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2021.773953","volume":"10","author":"JJ Kopper","year":"2021","unstructured":"Kopper, J. J. et al. Harnessing the biology of canine intestinal organoids to heighten understanding of inflammatory bowel disease pathogenesis and accelerate drug discovery: A one health approach. Front. Toxicol. 10(3), 773953. https:\/\/doi.org\/10.3389\/ftox.2021.773953 (2021).","journal-title":"Front. Toxicol."},{"issue":"4","key":"71202_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2460\/ajvr.79.4.411","volume":"79","author":"AK Masters","year":"2018","unstructured":"Masters, A. K. et al. Effects of short-term anti-inflammatory glucocorticoid treatment on clinicopathologic, echocardiographic, and hemodynamic variables in systemically healthy dogs. Am. J. Vet. Res. 79(4), 411\u2013423. https:\/\/doi.org\/10.2460\/ajvr.79.4.411 (2018) (PMID: 29583045).","journal-title":"Am. J. Vet. Res."},{"issue":"6","key":"71202_CR24","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/med.21716","volume":"40","author":"L Sebbag","year":"2020","unstructured":"Sebbag, L. & Mochel, J. P. An eye on the dog as the scientist\u2019s best friend for translational research in ophthalmology: Focus on the ocular surface. Med. Res. Rev. 40(6), 2566\u20132604. https:\/\/doi.org\/10.1002\/med.21716 (2020).","journal-title":"Med. Res. Rev."},{"issue":"1","key":"71202_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tvjl.2008.10.011","volume":"183","author":"PG Xenoulis","year":"2010","unstructured":"Xenoulis, P. G. & Steiner, J. M. Lipid metabolism and hyperlipidemia in dogs. Vet. J. 183(1), 12\u201321. https:\/\/doi.org\/10.1016\/j.tvjl.2008.10.011 (2010).","journal-title":"Vet. J."},{"issue":"3","key":"71202_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrendo.2017.161","volume":"14","author":"M Kleinert","year":"2018","unstructured":"Kleinert, M. et al. Animal models of obesity and diabetes mellitus. Nat. Rev. Endocrinol. 14(3), 140\u2013162. https:\/\/doi.org\/10.1038\/nrendo.2017.161 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"71202_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1194\/jlr.M019927","volume":"53","author":"W Yin","year":"2012","unstructured":"Yin, W. et al. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J. Lipid Res. 53(1), 51\u201365. https:\/\/doi.org\/10.1194\/jlr.M019927 (2012).","journal-title":"J. Lipid Res."},{"issue":"128","key":"71202_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejps.2018.11.037","volume":"1","author":"JP Mochel","year":"2019","unstructured":"Mochel, J. P. et al. Sacubitril\/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation. Eur. J. Pharm. Sci. 1(128), 103\u2013111. https:\/\/doi.org\/10.1016\/j.ejps.2018.11.037 (2019).","journal-title":"Eur. J. Pharm. Sci."},{"key":"71202_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/112_2015_27","volume":"169","author":"JP Mochel","year":"2015","unstructured":"Mochel, J. P. & Danhof, M. Chronobiology and pharmacologic modulation of the renin-angiotensin-aldosterone system in dogs: What have we learned?. Rev. Physiol. Biochem. Pharmacol. 169, 43\u201369. https:\/\/doi.org\/10.1007\/112_2015_27 (2015) (PMID: 26428686).","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"6","key":"71202_CR30","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s11095-014-1587-9","volume":"32","author":"JP Mochel","year":"2015","unstructured":"Mochel, J. P. et al. Pharmacokinetic\/pharmacodynamic modeling of renin-angiotensin aldosterone biomarkers following angiotensin-converting enzyme (ACE) inhibition therapy with benazepril in dogs. Pharm. Res. 32(6), 1931\u20131946. https:\/\/doi.org\/10.1007\/s11095-014-1587-9 (2015).","journal-title":"Pharm. Res."},{"issue":"2","key":"71202_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/psp4.12262","volume":"7","author":"B Schneider","year":"2018","unstructured":"Schneider, B. et al. Model-based reverse translation between veterinary and human medicine: The one health initiative. CPT Pharmacometrics Syst. Pharmacol. 7(2), 65\u201368. https:\/\/doi.org\/10.1002\/psp4.12262 (2018).","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"7","key":"71202_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.566282","volume":"25","author":"A Moinard","year":"2020","unstructured":"Moinard, A. et al. Effects of high-fat diet at two energetic levels on fecal microbiota, colonic barrier, and metabolic parameters in dogs. Front. Vet. Sci. 25(7), 566282. https:\/\/doi.org\/10.3389\/fvets.2020.566282 (2020).","journal-title":"Front. Vet. Sci."},{"issue":"9","key":"71202_CR33","doi-asserted-by":"publisher","first-page":"1019615","DOI":"10.3389\/fnut.2022.1019615","volume":"24","author":"J Xue","year":"2022","unstructured":"Xue, J. et al. A protein- and fiber-rich diet with astaxanthin alleviates high-fat diet-induced obesity in beagles. Front. Nutr. 24(9), 1019615. https:\/\/doi.org\/10.3389\/fnut.2022.1019615 (2022).","journal-title":"Front. Nutr."},{"issue":"9","key":"71202_CR34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1292\/jvms.13-0475","volume":"76","author":"C Pe\u00f1a","year":"2014","unstructured":"Pe\u00f1a, C. et al. Effects of low-fat high-fiber diet and mitratapide on body weight reduction, blood pressure and metabolic parameters in obese dogs. J. Vet. Med. Sci. 76(9), 1305\u20131308. https:\/\/doi.org\/10.1292\/jvms.13-0475 (2014).","journal-title":"J. Vet. Med. Sci."},{"issue":"4","key":"71202_CR35","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/metabo13040554","volume":"13","author":"H Sun","year":"2023","unstructured":"Sun, H. et al. Different diet energy levels alter body condition, glucolipid metabolism, fecal microbiota and metabolites in adult beagle dogs. Metabolites 13(4), 554. https:\/\/doi.org\/10.3390\/metabo13040554 (2023).","journal-title":"Metabolites"},{"issue":"8","key":"71202_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1746-6148-8-147","volume":"28","author":"A Tvarijonaviciute","year":"2012","unstructured":"Tvarijonaviciute, A. et al. Obesity-related metabolic dysfunction in dogs: A comparison with human metabolic syndrome. BMC Vet. Res. 28(8), 147. https:\/\/doi.org\/10.1186\/1746-6148-8-147 (2012).","journal-title":"BMC Vet. Res."},{"issue":"13","key":"71202_CR37","doi-asserted-by":"publisher","first-page":"1050474","DOI":"10.3389\/fmicb.2022.1050474","volume":"12","author":"CG Vecchiato","year":"2023","unstructured":"Vecchiato, C. G. et al. Fecal microbiota and inflammatory and antioxidant status of obese and lean dogs, and the effect of caloric restriction. Front. Microbiol. 12(13), 1050474. https:\/\/doi.org\/10.3389\/fmicb.2022.1050474 (2023).","journal-title":"Front. Microbiol."},{"issue":"6","key":"71202_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/eurheartj\/ehp487","volume":"31","author":"A Romero-Corral","year":"2010","unstructured":"Romero-Corral, A. et al. Normal weight obesity: A risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur. Heart J. 31(6), 737\u2013746. https:\/\/doi.org\/10.1093\/eurheartj\/ehp487 (2010).","journal-title":"Eur. Heart J."},{"issue":"17","key":"71202_CR39","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.5888\/pcd17.200020","volume":"21","author":"TH Shi","year":"2020","unstructured":"Shi, T. H., Wang, B. & Natarajan, S. The influence of metabolic syndrome in predicting mortality risk among US adults: Importance of metabolic syndrome even in adults with normal weight. Prev. Chronic Dis. 21(17), E36. https:\/\/doi.org\/10.5888\/pcd17.200020 (2020).","journal-title":"Prev. Chronic Dis."},{"issue":"7","key":"71202_CR40","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/ndt\/gfac040","volume":"37","author":"EMPA-KIDNEY Collaborative Group","year":"2022","unstructured":"EMPA-KIDNEY Collaborative Group. Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial. Nephrol. Dial. Transpl. 37(7), 1317\u20131329. https:\/\/doi.org\/10.1093\/ndt\/gfac040 (2022).","journal-title":"Nephrol. Dial. Transpl."},{"issue":"31","key":"71202_CR41","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/eurheartj\/ehab530","volume":"43","author":"K Oyama","year":"2022","unstructured":"Oyama, K. et al. Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial. Eur. Heart J. 43(31), 2958\u20132967. https:\/\/doi.org\/10.1093\/eurheartj\/ehab530 (2022) (PMID: 34427295).","journal-title":"Eur. Heart J."},{"issue":"10","key":"71202_CR42","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","volume":"35","author":"DC Wheeler","year":"2020","unstructured":"Wheeler, D. C. et al. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics. Nephrol. Dial. Transp. 35(10), 1700\u20131711. https:\/\/doi.org\/10.1093\/ndt\/gfaa234 (2020).","journal-title":"Nephrol. Dial. Transp."},{"issue":"10","key":"71202_CR43","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/ejhf.2308","volume":"23","author":"C Adamson","year":"2021","unstructured":"Adamson, C. et al. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. Eur. J. Heart Fail. 23(10), 1662\u20131672. https:\/\/doi.org\/10.1002\/ejhf.2308 (2021).","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"71202_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/jas\/skab235.104","volume":"99","author":"CA Iennarella-Servantez","year":"2021","unstructured":"Iennarella-Servantez, C. A. et al. Diet-induced clinical responsiveness of translational dog model for human western diet (WD)-related disease research. J. Anim. Sci. 99(3), 58\u201359. https:\/\/doi.org\/10.1093\/jas\/skab235.104 (2021).","journal-title":"J. Anim. Sci."},{"issue":"7 Suppl","key":"71202_CR45","doi-asserted-by":"publisher","first-page":"2031S","DOI":"10.1093\/jn\/136.7.2031S","volume":"136","author":"AJ German","year":"2006","unstructured":"German, A. J. et al. A simple, reliable tool for owners to assess the body condition of their dog or cat. J. Nutr. 136(7 Suppl), 2031S-2033S. https:\/\/doi.org\/10.1093\/jn\/136.7.2031S (2006) (PMID: 16772488).","journal-title":"J. Nutr."},{"key":"71202_CR46","unstructured":"National Health and Nutrition Examination Survey. (NHANES 2015\u20132016: Males and Females over 20 years). https:\/\/www.ars.usda.gov\/northeast-area\/beltsville-md-bhnrc\/beltsville-human-nutrition-research-center\/food-surveys-research-group\/docs\/temp-wweia-usual-intake-data-tables\/."},{"key":"71202_CR47","volume-title":"Nutrient Requirements of Dogs and Cats","author":"National Research Council","year":"2006","unstructured":"National Research Council. Nutrient Requirements of Dogs and Cats (The National Academies Press, Washington, 2006)."},{"issue":"6","key":"71202_CR48","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/jvim.15331","volume":"32","author":"MJ Acierno","year":"2018","unstructured":"Acierno, M. J. et al. ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J. Vet. Intern. Med. 32(6), 1803\u20131822. https:\/\/doi.org\/10.1111\/jvim.15331 (2018).","journal-title":"J. Vet. Intern. Med."},{"key":"71202_CR49","unstructured":"Larner, C. D. High performance lipoprotein profiling for cardiovascular risk assessment. PhD thesis, Texas A&M University (2012)."},{"issue":"4","key":"71202_CR50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/1098612X18780060","volume":"21","author":"T Minamoto","year":"2019","unstructured":"Minamoto, T. et al. Altered lipoprotein profiles in cats with hepatic lipidosis. J. Feline Med. Surg. 21(4), 363\u2013372. https:\/\/doi.org\/10.1177\/1098612X18780060 (2019).","journal-title":"J. Feline Med. Surg."},{"issue":"1","key":"71202_CR51","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1038\/s41598-023-30453-x","volume":"13","author":"BK Schneider","year":"2023","unstructured":"Schneider, B. K. et al. Breakthrough: A first-in-class virtual simulator for dose optimization of ACE inhibitors in translational cardiovascular medicine. Sci. Rep. 13(1), 3300. https:\/\/doi.org\/10.1038\/s41598-023-30453-x (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"71202_CR52","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/s41598-023-29771-x","volume":"13","author":"S Sotillo","year":"2023","unstructured":"Sotillo, S. et al. Dose-response of benazepril on biomarkers of the classical and alternative pathways of the renin-angiotensin-aldosterone system in dogs. Sci. Rep. 13(1), 2684. https:\/\/doi.org\/10.1038\/s41598-023-29771-x (2023).","journal-title":"Sci. Rep."},{"issue":"5","key":"71202_CR53","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/jvim.16236","volume":"35","author":"JL Ward","year":"2021","unstructured":"Ward, J. L., Chou, Y. Y., Yuan, L., Dorman, K. S. & Mochel, J. P. Retrospective evaluation of a dose-dependent effect of angiotensin-converting enzyme inhibitors on long-term outcome in dogs with cardiac disease. J. Vet. Intern. Med. 35(5), 2102\u20132111. https:\/\/doi.org\/10.1111\/jvim.16236 (2021).","journal-title":"J. Vet. Intern. Med."},{"issue":"3","key":"71202_CR54","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jvim.16401","volume":"36","author":"JL Ward","year":"2022","unstructured":"Ward, J. L. et al. Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy. J. Vet. Intern. Med. 36(3), 897\u2013909. https:\/\/doi.org\/10.1111\/jvim.16401 (2022).","journal-title":"J. Vet. Intern. Med."},{"issue":"6","key":"71202_CR55","doi-asserted-by":"publisher","first-page":"33678","DOI":"10.1038\/srep33678","volume":"21","author":"O Domenig","year":"2016","unstructured":"Domenig, O. et al. Neprilysin is a mediator of alternative renin-angiotensin-system activation in the Murine and human kidney. Sci. Rep. 21(6), 33678. https:\/\/doi.org\/10.1038\/srep33678 (2016).","journal-title":"Sci. Rep."},{"issue":"3","key":"71202_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/clinchem\/hvaa001","volume":"66","author":"Z Guo","year":"2020","unstructured":"Guo, Z. et al. Measurement of equilibrium angiotensin II in the diagnosis of primary aldosteronism. Clin. Chem. 66(3), 483\u2013492. https:\/\/doi.org\/10.1093\/clinchem\/hvaa001 (2020) (PMID: 32068832).","journal-title":"Clin. Chem."},{"issue":"11","key":"71202_CR57","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","volume":"8","author":"A Zoufaly","year":"2020","unstructured":"Zoufaly, A. et al. Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir. Med. 8(11), 1154\u20131158. https:\/\/doi.org\/10.1016\/S2213-2600(20)30418-5 (2020).","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"71202_CR58","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/antiox11020424","volume":"11","author":"LG Gonz\u00e1lez-Arostegui","year":"2022","unstructured":"Gonz\u00e1lez-Arostegui, L. G., Mu\u00f1oz-Prieto, A., Tvarijonaviciute, A., Cer\u00f3n, J. J. & Rubio, C. P. Measurement of redox biomarkers in the whole blood and red blood cell lysates of dogs. Antioxidants (Basel) 11(2), 424. https:\/\/doi.org\/10.3390\/antiox11020424 (2022).","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"71202_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ab.2009.05.024","volume":"392","author":"C Campos","year":"2009","unstructured":"Campos, C., Guzm\u00e1n, R., L\u00f3pez-Fern\u00e1ndez, E. & Casado, A. Evaluation of the copper(II) reduction assay using bathocuproinedisulfonic acid disodium salt for the total antioxidant capacity assessment: The CUPRAC-BCS assay. Anal. Biochem. 392(1), 37\u201344. https:\/\/doi.org\/10.1016\/j.ab.2009.05.024 (2009) (Epub 2009 May 21 PMID: 19464250).","journal-title":"Anal. Biochem."},{"issue":"6","key":"71202_CR60","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/1040638716664939","volume":"28","author":"CP Rubio","year":"2016","unstructured":"Rubio, C. P. et al. Validation of three automated assays for total antioxidant capacity determination in canine serum samples. J. Vet. Diagn. Invest. 28(6), 693\u2013698. https:\/\/doi.org\/10.1177\/1040638716664939 (2016).","journal-title":"J. Vet. Diagn. Invest."},{"issue":"1","key":"71202_CR61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IF Benzie","year":"1996","unstructured":"Benzie, I. F. & Strain, J. J. The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: The FRAP assay. Anal. Biochem. 239(1), 70\u201376. https:\/\/doi.org\/10.1006\/abio.1996.0292 (1996) (PMID: 8660627).","journal-title":"Anal. Biochem."},{"issue":"2","key":"71202_CR62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1006\/abio.1996.0164","volume":"236","author":"MB Arnao","year":"1996","unstructured":"Arnao, M. B., Cano, A., Hern\u00e1ndez-Ruiz, J., Garc\u00eda-C\u00e1novas, F. & Acosta, M. Inhibition by L-ascorbic acid and other antioxidants of the 2.2\u2019-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) oxidation catalyzed by peroxidase: A new approach for determining total antioxidant status of foods. Anal. Biochem. 236(2), 255\u2013261. https:\/\/doi.org\/10.1006\/abio.1996.0164 (1996).","journal-title":"Anal. Biochem."},{"key":"71202_CR63","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1590\/S1676-24442006000500006","volume":"42","author":"CM Da Costa","year":"2006","unstructured":"Da Costa, C. M., Dos Santos, R. C. C. & Lima, E. S. A simple automated procedure for thiol measurement in human serum samples. J. Bras. Patol. Med. Lab. 42, 345\u2013350. https:\/\/doi.org\/10.1590\/S1676-24442006000500006 (2006).","journal-title":"J. Bras. Patol. Med. Lab."},{"issue":"1","key":"71202_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2460\/ajvr.73.1.34","volume":"73","author":"A Tvarijonaviciute","year":"2012","unstructured":"Tvarijonaviciute, A., Tecles, F., Caldin, M., Tasca, S. & Cer\u00f3n, J. Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs. Am. J. Vet. Res. 73(1), 34\u201341. https:\/\/doi.org\/10.2460\/ajvr.73.1.34 (2012) (PMID: 22204286).","journal-title":"Am. J. Vet. Res."},{"issue":"3","key":"71202_CR65","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.rvsc.2011.04.014","volume":"92","author":"AP Kapun","year":"2012","unstructured":"Kapun, A. P., Salobir, J., Levart, A., Kotnik, T. & Svete, A. N. Oxidative stress markers in canine atopic dermatitis. Res. Vet. Sci. 92(3), 469\u2013470. https:\/\/doi.org\/10.1016\/j.rvsc.2011.04.014 (2012).","journal-title":"Res. Vet. Sci."},{"issue":"5","key":"71202_CR66","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/1040638717711995","volume":"29","author":"B Verk","year":"2017","unstructured":"Verk, B., Nemec Svete, A., Salobir, J., Rezar, V. & Domanjko, P. A. Markers of oxidative stress in dogs with heart failure. J. Vet. Diagn. Invest. 29(5), 636\u2013644. https:\/\/doi.org\/10.1177\/1040638717711995 (2017).","journal-title":"J. Vet. Diagn. Invest."},{"issue":"12","key":"71202_CR67","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel, O. A new automated colorimetric method for measuring total oxidant status. Clin. Biochem. 38(12), 1103\u20131111. https:\/\/doi.org\/10.1016\/j.clinbiochem.2005.08.008 (2005) (Epub 2005 Oct 7 PMID: 16214125).","journal-title":"Clin. Biochem."},{"issue":"2","key":"71202_CR68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0003-2697(02)00652-8","volume":"316","author":"F Tatzber","year":"2003","unstructured":"Tatzber, F., Griebenow, S., Wonisch, W. & Winkler, R. Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. Anal. Biochem. 316(2), 147\u2013153. https:\/\/doi.org\/10.1016\/s0003-2697(02)00652-8 (2003) (PMID: 12711334).","journal-title":"Anal. Biochem."},{"key":"71202_CR69","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1163\/156856700X00769","volume":"26","author":"A Alberti","year":"2000","unstructured":"Alberti, A., Bolognini, L., Macciantelli, D. & Caratelli, M. The radical cation of N, N-diethyl-para-phenylendiamine: A possible indicator of oxidative stress in biological samples. Res. Chem. Intermed. 26, 253\u2013267. https:\/\/doi.org\/10.1163\/156856700X00769 (2000).","journal-title":"Res. Chem. Intermed."},{"key":"71202_CR70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.rvsc.2018.09.007","volume":"121","author":"CP Rubio","year":"2018","unstructured":"Rubio, C. P. et al. Stability of biomarkers of oxidative stress in canine serum. Res. Vet. Sci. 121, 85\u201393. https:\/\/doi.org\/10.1016\/j.rvsc.2018.09.007 (2018).","journal-title":"Res. Vet. Sci."},{"issue":"5","key":"71202_CR71","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ki.1996.186","volume":"49","author":"V Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat, V. et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49(5), 1304\u20131313. https:\/\/doi.org\/10.1038\/ki.1996.186 (1996) (PMID: 8731095).","journal-title":"Kidney Int."},{"issue":"5","key":"71202_CR72","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49(5), 1137\u20131146. https:\/\/doi.org\/10.1194\/jlr.D700041-JLR200 (2008).","journal-title":"J. Lipid Res."},{"issue":"3","key":"71202_CR73","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","volume":"3","author":"LW Sumner","year":"2007","unstructured":"Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics 3(3), 211\u2013221. https:\/\/doi.org\/10.1007\/s11306-007-0082-2 (2007).","journal-title":"Metabolomics"},{"issue":"28","key":"71202_CR74","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.1007\/s00216-017-0628-8","volume":"409","author":"LA Adutwum","year":"2017","unstructured":"Adutwum, L. A., de la Mata, A. P., Bean, H. D., Hill, J. E. & Harynuk, J. J. Estimation of start and stop numbers for cluster resolution feature selection algorithm: An empirical approach using null distribution analysis of Fisher ratios. Anal. Bioanal. Chem. 409(28), 6699\u20136708. https:\/\/doi.org\/10.1007\/s00216-017-0628-8 (2017).","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"71202_CR75","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.talanta.2010.10.025","volume":"83","author":"NA Sinkov","year":"2011","unstructured":"Sinkov, N. A. & Harynuk, J. J. Cluster resolution: A metric for automated, objective and optimized feature selection in chemometric modeling. Talanta 83(4), 1079\u20131087. https:\/\/doi.org\/10.1016\/j.talanta.2010.10.025 (2011).","journal-title":"Talanta"},{"key":"71202_CR76","doi-asserted-by":"publisher","first-page":"801863","DOI":"10.3389\/fvets.2022.801863","volume":"9","author":"Y Lyu","year":"2022","unstructured":"Lyu, Y. et al. Differences in metabolic profiles of healthy dogs fed a high-fat vs. a high-starch diet. Front. Vet. Sci. 9, 801863. https:\/\/doi.org\/10.3389\/fvets.2022.801863 (2022).","journal-title":"Front. Vet. Sci."},{"issue":"3","key":"71202_CR77","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1172\/JCI10761","volume":"106","author":"MK Cavaghan","year":"2000","unstructured":"Cavaghan, M. K., Ehrmann, D. A. & Polonsky, K. S. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J. Clin. Invest. 106(3), 329\u2013333. https:\/\/doi.org\/10.1172\/JCI10761 (2000).","journal-title":"J. Clin. Invest."},{"key":"71202_CR78","unstructured":"Rix, I., Nex\u00f8e-Larsen, C., Bergmann, N. C., Lund, A. & Knop, F. K. Glucagon Physiology. In: Feingold, K. R., Anawalt, B., Blackman, M. R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W. W., Dhatariya, K., Dungan, K., Hofland, J., Kalra, S., Kaltsas, G., Kapoor, N., Koch, C., Kopp, P., Korbonits, M., Kovacs, C. S., Kuohung, W., Laferr\u00e8re, B., Levy, M., McGee, E. A., McLachlan, R., New, M., Purnell, J., Sahay, R., Shah, A. S., Singer, F., Sperling, M. A., Stratakis, C. A., Trence, D. L. & Wilson, D. P., (eds). South Dartmouth (MA): MDText.com, Inc. (2000)."},{"key":"71202_CR79","unstructured":"Burger, M. & Schaller, D. J. Metabolic Acidosis. 2023 Jul 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID: 29489167 (2023)."},{"issue":"4","key":"71202_CR80","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00424-024-02910-7","volume":"476","author":"MLAJ Wie\u00ebrs","year":"2024","unstructured":"Wie\u00ebrs, M. L. A. J., Beynon-Cobb, B., Visser, W. J. & Attaye, I. Dietary acid load in health and disease. Pflugers Arch. 476(4), 427\u2013443. https:\/\/doi.org\/10.1007\/s00424-024-02910-7 (2024).","journal-title":"Pflugers Arch."},{"key":"71202_CR81","unstructured":"Sharma, S., Hashmi, M. F. & Aggarwal, S. Hyperchloremic Acidosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing (2023)."},{"issue":"3","key":"71202_CR82","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s40746-022-00240-3","volume":"8","author":"OF Bamgbola","year":"2022","unstructured":"Bamgbola, O. F. Review of the pathophysiologic and clinical aspects of hypokalemia in children and young adults: An Update. Curr. Treat Options Pediatr. 8(3), 96\u2013114. https:\/\/doi.org\/10.1007\/s40746-022-00240-3 (2022).","journal-title":"Curr. Treat Options Pediatr."},{"key":"71202_CR83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-4684-4259-5_30","volume":"151","author":"D Batlle","year":"1982","unstructured":"Batlle, D. et al. Proximal renal tubular acidosis and hypophosphatemia induced by arginine. Adv. Exp. Med. Biol. 151, 239\u2013249. https:\/\/doi.org\/10.1007\/978-1-4684-4259-5_30 (1982) (PMID: 6817609).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"71202_CR84","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13256-019-2056-1","volume":"13","author":"G Vasquez-Rios","year":"2019","unstructured":"Vasquez-Rios, G., Westrich, D. J. Jr., Philip, I., Edwards, J. C. & Shieh, S. Distal renal tubular acidosis and severe hypokalemia: A case report and review of the literature. J. Med. Case Rep. 13(1), 103. https:\/\/doi.org\/10.1186\/s13256-019-2056-1 (2019).","journal-title":"J. Med. Case Rep."},{"issue":"11","key":"71202_CR85","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.34067\/KID.0002402022","volume":"3","author":"DC Lambert","year":"2022","unstructured":"Lambert, D. C., Kane, J., Slaton, A. & Abramowitz, M. K. Associations of metabolic syndrome and abdominal obesity with anion gap metabolic acidosis among US adults. Kidney360 3(11), 1842\u20131851. https:\/\/doi.org\/10.34067\/KID.0002402022 (2022).","journal-title":"Kidney360"},{"issue":"3","key":"71202_CR86","first-page":"255","volume":"9","author":"M Stoian","year":"2014","unstructured":"Stoian, M. & Stoica, V. The role of distubances of phosphate metabolism in metabolic syndrome. Maedica (Bucur) 9(3), 255\u2013260 (2014).","journal-title":"Maedica (Bucur)"},{"issue":"3","key":"71202_CR87","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.clnu.2013.07.010","volume":"33","author":"K Sun","year":"2014","unstructured":"Sun, K. et al. Serum potassium level is associated with metabolic syndrome: A population-based study. Clin. Nutr. 33(3), 521\u2013527. https:\/\/doi.org\/10.1016\/j.clnu.2013.07.010 (2014).","journal-title":"Clin. Nutr."},{"issue":"5","key":"71202_CR88","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2005.01.005","volume":"45","author":"R Kalaitzidis","year":"2005","unstructured":"Kalaitzidis, R., Tsimihodimos, V., Bairaktari, E., Siamopoulos, K. C. & Elisaf, M. Disturbances of phosphate metabolism: Another feature of metabolic syndrome. Am. J. Kidney Dis. 45(5), 851\u2013858. https:\/\/doi.org\/10.1053\/j.ajkd.2005.01.005 (2005) (PMID: 15861350).","journal-title":"Am. J. Kidney Dis."},{"issue":"3\u20134","key":"71202_CR89","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000480354","volume":"71","author":"M Shimodaira","year":"2017","unstructured":"Shimodaira, M., Okaniwa, S. & Nakayama, T. Reduced serum phosphorus levels were associated with metabolic syndrome in men but not in women: A cross-sectional study among the Japanese population. Ann. Nutr. Metab. 71(3\u20134), 150\u2013156. https:\/\/doi.org\/10.1159\/000480354 (2017).","journal-title":"Ann. Nutr. Metab."},{"issue":"4","key":"71202_CR90","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/jvim.14775","volume":"31","author":"M Tropf","year":"2017","unstructured":"Tropf, M., Nelson, O. L., Lee, P. M. & Weng, H. Y. Cardiac and metabolic variables in obese dogs. J. Vet. Intern. Med. 31(4), 1000\u20131007. https:\/\/doi.org\/10.1111\/jvim.14775 (2017).","journal-title":"J. Vet. Intern. Med."},{"issue":"5","key":"71202_CR91","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jacc.2020.11.063","volume":"77","author":"A Hussain","year":"2021","unstructured":"Hussain, A. et al. Association of NT-ProBNP, blood pressure, and cardiovascular events: The ARIC study. J. Am. Coll. Cardiol. 77(5), 559\u2013571. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.063 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"71202_CR92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13620-023-00233-0","volume":"76","author":"IS Jang","year":"2023","unstructured":"Jang, I. S., Yoon, W. K. & Choi, E. W. N-terminal pro-B-type natriuretic peptide levels in normotensive and hypertensive dogs with myxomatous mitral valve disease stage B. Ir. Vet. J. 76(1), 3. https:\/\/doi.org\/10.1186\/s13620-023-00233-0 (2023).","journal-title":"Ir. Vet. J."},{"key":"71202_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3036","author":"A Bayes-Genis","year":"2023","unstructured":"Bayes-Genis, A. et al. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the heart failure association of the ESC. Eur. J. Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.3036 (2023).","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"71202_CR94","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/j.1939-1676.2012.1000.x","volume":"26","author":"GE Singletary","year":"2012","unstructured":"Singletary, G. E., Morris, N. A., Lynne O\u2019Sullivan, M., Gordon, S. G. & Oyama, M. A. Prospective evaluation of NT-proBNP assay to detect occult dilated cardiomyopathy and predict survival in Doberman Pinschers. J. Vet. Intern. Med. 26(6), 1330\u20131336. https:\/\/doi.org\/10.1111\/j.1939-1676.2012.1000.x (2012).","journal-title":"J. Vet. Intern. Med."},{"issue":"2","key":"71202_CR95","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/jvim.16083","volume":"35","author":"J Wilshaw","year":"2021","unstructured":"Wilshaw, J. et al. Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease. J. Vet. Intern. Med. 35(2), 755\u2013770. https:\/\/doi.org\/10.1111\/jvim.16083 (2021).","journal-title":"J. Vet. Intern. Med."},{"issue":"1","key":"71202_CR96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCOUTCOMES.113.000675","volume":"7","author":"AO Akinkuolie","year":"2014","unstructured":"Akinkuolie, A. O., Paynter, N. P., Padmanabhan, L. & Mora, S. High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease. Circ. Cardiovasc. Qual. Outcomes 7(1), 55\u201363. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.113.000675 (2014).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"6","key":"71202_CR97","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jacl.2012.03.001","volume":"6","author":"HR Superko","year":"2012","unstructured":"Superko, H. R. et al. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J. Clin. Lipidol. 6(6), 496\u2013523. https:\/\/doi.org\/10.1016\/j.jacl.2012.03.001 (2012).","journal-title":"J. Clin. Lipidol."},{"issue":"1","key":"71202_CR98","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12883-020-01989-6","volume":"20","author":"R Duan","year":"2020","unstructured":"Duan, R. et al. Estimation of the LDL subclasses in ischemic stroke as a risk factor in a Chinese population. BMC Neurol. 20(1), 414. https:\/\/doi.org\/10.1186\/s12883-020-01989-6 (2020).","journal-title":"BMC Neurol."},{"key":"71202_CR99","doi-asserted-by":"publisher","first-page":"8675283","DOI":"10.1155\/2016\/8675283","volume":"2016","author":"JM Lahm Cardoso","year":"2016","unstructured":"Lahm Cardoso, J. M. et al. Blood pressure, serum glucose, cholesterol, and triglycerides in dogs with different body scores. Vet. Med. Int. 2016, 8675283. https:\/\/doi.org\/10.1155\/2016\/8675283 (2016).","journal-title":"Vet. Med. Int."},{"key":"71202_CR100","doi-asserted-by":"publisher","first-page":"101869","DOI":"10.1016\/j.redox.2021.101869","volume":"42","author":"K Aleksandrova","year":"2021","unstructured":"Aleksandrova, K., Koelman, L. & Rodrigues, C. E. Dietary patterns and biomarkers of oxidative stress and inflammation: A systematic review of observational and intervention studies. Redox Biol. 42, 101869. https:\/\/doi.org\/10.1016\/j.redox.2021.101869 (2021).","journal-title":"Redox Biol."},{"issue":"304","key":"71202_CR101","doi-asserted-by":"publisher","first-page":"304re7","DOI":"10.1126\/scitranslmed.aac4765","volume":"7","author":"G Boden","year":"2015","unstructured":"Boden, G. et al. Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. Sci. Transl. Med. 7(304), 304re7. https:\/\/doi.org\/10.1126\/scitranslmed.aac4765 (2015).","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"71202_CR102","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.metabol.2008.03.010","volume":"57","author":"N Matsuzawa-Nagata","year":"2008","unstructured":"Matsuzawa-Nagata, N. et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57(8), 1071\u20131077. https:\/\/doi.org\/10.1016\/j.metabol.2008.03.010 (2008) (PMID: 18640384).","journal-title":"Metabolism"},{"key":"71202_CR103","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jveb.2019.12.003","volume":"37","author":"B Chiofalo","year":"2020","unstructured":"Chiofalo, B. et al. Effects of dietary protein and fat concentrations on hormonal and oxidative blood stress biomarkers in guide dogs during training. J. Vet. Behav. 37, 86\u201392. https:\/\/doi.org\/10.1016\/j.jveb.2019.12.003 (2020).","journal-title":"J. Vet. Behav."},{"issue":"13","key":"71202_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.849060","volume":"19","author":"W Qu","year":"2022","unstructured":"Qu, W. et al. Profound perturbation in the metabolome of a canine obesity and metabolic disorder model. Front. Endocrinol. (Lausanne) 19(13), 849060. https:\/\/doi.org\/10.3389\/fendo.2022.849060 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"71202_CR105","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.molmet.2021.101195","volume":"49","author":"S Amjad","year":"2021","unstructured":"Amjad, S. et al. Role of NAD+ in regulating cellular and metabolic signaling pathways. Mol. Metab. 49, 101195. https:\/\/doi.org\/10.1016\/j.molmet.2021.101195 (2021).","journal-title":"Mol. Metab."},{"issue":"2010","key":"71202_CR106","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/157591","volume":"25","author":"D Surjana","year":"2010","unstructured":"Surjana, D., Halliday, G. M. & Damian, D. L. Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J. Nucleic Acids. 25(2010), 157591. https:\/\/doi.org\/10.4061\/2010\/157591 (2010).","journal-title":"J. Nucleic Acids."},{"issue":"1","key":"71202_CR107","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S095442241400002X","volume":"27","author":"G Fr\u00fchbeck","year":"2014","unstructured":"Fr\u00fchbeck, G., M\u00e9ndez-Gim\u00e9nez, L., Fern\u00e1ndez-Formoso, J. A., Fern\u00e1ndez, S. & Rodr\u00edguez, A. Regulation of adipocyte lipolysis. Nutr. Res. Rev. 27(1), 63\u201393. https:\/\/doi.org\/10.1017\/S095442241400002X (2014) (Epub 2014 May 28 PMID: 24872083).","journal-title":"Nutr. Res. Rev."},{"key":"71202_CR108","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1201\/9780203500002-3","volume-title":"Vitamin C, Function and Biochemistry in Animals and Plants","author":"G B\u00e1nhegyi","year":"2004","unstructured":"B\u00e1nhegyi, G. & Loewus, F. A. Ascorbic acid catabolism: Breakdown pathways in animals and plants. In Vitamin C, Function and Biochemistry in Animals and Plants (eds Asard, H. et al.) 35 (Taylor & Francis, New York, 2004)."},{"issue":"5","key":"71202_CR109","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1194\/jlr.R046094","volume":"55","author":"D Hishikawa","year":"2014","unstructured":"Hishikawa, D., Hashidate, T., Shimizu, T. & Shindou, H. Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells. J. Lipid Res. 55(5), 799\u2013807. https:\/\/doi.org\/10.1194\/jlr.R046094 (2014).","journal-title":"J. Lipid Res."},{"key":"71202_CR110","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pharmthera.2016.04.007","volume":"164","author":"S Sivaprakasam","year":"2016","unstructured":"Sivaprakasam, S., Prasad, P. D. & Singh, N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol. Ther. 164, 144\u2013151. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.04.007 (2016).","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"71202_CR111","doi-asserted-by":"publisher","first-page":"CD011737","DOI":"10.1002\/14651858.CD011737.pub2","volume":"5","author":"L Hooper","year":"2020","unstructured":"Hooper, L. et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst. Rev. 5(5), CD011737. https:\/\/doi.org\/10.1002\/14651858.CD011737.pub2 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"71202_CR112","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3945\/ajcn.2008.26285","volume":"91","author":"PW Siri-Tarino","year":"2010","unstructured":"Siri-Tarino, P. W., Sun, Q., Hu, F. B. & Krauss, R. M. Saturated fat, carbohydrate, and cardiovascular disease. Am. J. Clin. Nutr. 91(3), 502\u2013509. https:\/\/doi.org\/10.3945\/ajcn.2008.26285 (2010).","journal-title":"Am. J. Clin. Nutr."},{"issue":"13","key":"71202_CR113","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1476-511X-13-199","volume":"20","author":"A Bolsoni-Lopes","year":"2014","unstructured":"Bolsoni-Lopes, A. et al. Palmitoleic acid (n-7) increases white adipocytes GLUT4 content and glucose uptake in association with AMPK activation. Lipids Health Dis. 20(13), 199. https:\/\/doi.org\/10.1186\/1476-511X-13-199 (2014).","journal-title":"Lipids Health Dis."},{"issue":"1","key":"71202_CR114","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-018-0710-z","volume":"17","author":"MM Cruz","year":"2018","unstructured":"Cruz, M. M. et al. Palmitoleic acid (16:1n7) increases oxygen consumption, fatty acid oxidation and ATP content in white adipocytes. Lipids Health Dis. 17(1), 55. https:\/\/doi.org\/10.1186\/s12944-018-0710-z (2018).","journal-title":"Lipids Health Dis."},{"issue":"1","key":"71202_CR115","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3168\/jds.S0022-0302(06)72081-1","volume":"89","author":"SP Alves","year":"2006","unstructured":"Alves, S. P., Marcelino, C., Portugal, P. V. & Bessa, R. J. Short communication: The nature of heptadecenoic acid in ruminant fats. J. Dairy Sci. 89(1), 170\u2013173. https:\/\/doi.org\/10.3168\/jds.S0022-0302(06)72081-1 (2006) (PMID: 16357280).","journal-title":"J. Dairy Sci."},{"key":"71202_CR116","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.trac.2008.05.011","volume":"27","author":"JM Amigo","year":"2008","unstructured":"Amigo, J. M., Skov, T., Bro, R., Coello, J. & Maspoch, S. Solving GC-MS problems with PARAFAC2. TrAC Trends Anal. Chem. 27, 714\u2013725. https:\/\/doi.org\/10.1016\/j.trac.2008.05.011 (2008).","journal-title":"TrAC Trends Anal. Chem."},{"key":"71202_CR117","doi-asserted-by":"publisher","first-page":"463499","DOI":"10.1016\/j.chroma.2022.463499","volume":"1682","author":"RT Giebelhaus","year":"2022","unstructured":"Giebelhaus, R. T., Sorochan Armstrong, M. D., de la Mata, A. P. & Harynuk, J. J. Untargeted region of interest selection for gas chromatography\u2013mass spectrometry data using a pseudo F-ratio moving window. J. Chromatogr. A 1682, 463499. https:\/\/doi.org\/10.1016\/j.chroma.2022.463499 (2022).","journal-title":"J. Chromatogr. A"},{"key":"71202_CR118","doi-asserted-by":"publisher","first-page":"119","DOI":"10.12688\/f1000research.124194.1","volume":"11","author":"RT Giebelhaus","year":"2022","unstructured":"Giebelhaus, R. T., Erland, L. A. E. & Murch, S. J. HormonomicsDB: A novel workflow for the untargeted analysis of plant growth regulators and hormones. F1000Research 11, 119 (2022).","journal-title":"F1000Research"},{"issue":"1","key":"71202_CR119","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41598-019-56909-7","volume":"10","author":"S Monnerie","year":"2020","unstructured":"Monnerie, S. et al. Metabolomic and lipidomic signatures of metabolic syndrome and its physiological components in adults: A systematic review. Sci. Rep. 10(1), 669. https:\/\/doi.org\/10.1038\/s41598-019-56909-7 (2020).","journal-title":"Sci. Rep."},{"issue":"12","key":"71202_CR120","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","volume":"24","author":"T Kadowaki","year":"2022","unstructured":"Kadowaki, T. et al. Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan. Diabetes Obes. Metab. 24(12), 2283\u20132296. https:\/\/doi.org\/10.1111\/dom.14829 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"71202_CR121","unstructured":"National Heart, Lung, and Blood Institute (NHLBI). What is metabolic syndrome? https:\/\/www.nhlbi.nih.gov\/health\/metabolic-syndrome#:~:text=Metabolic%20syndrome%20is%20a%20group,also%20called%20insulin%20resistance%20syndrome. Last 18 May 2022."},{"key":"71202_CR122","unstructured":"R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/"},{"issue":"4","key":"71202_CR123","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/1040638717693883","volume":"29","author":"CP Rubio","year":"2017","unstructured":"Rubio, C. P., Martinez-Subiela, S., Hern\u00e1ndez-Ruiz, J., Tvarijonaviciute, A. & Ceron, J. J. Analytical validation of an automated assay for ferric-reducing ability of plasma in dog serum. J. Vet. Diagn. Invest. 29(4), 574\u2013578. https:\/\/doi.org\/10.1177\/1040638717693883 (2017).","journal-title":"J. Vet. Diagn. Invest."},{"key":"71202_CR124","unstructured":"Johnson, M. C. Hyperlipidemia disorders in dogs. Compend. Contin. Educat. Pract. Vet. 27, 361\u2013364 (2005)."},{"key":"71202_CR125","doi-asserted-by":"publisher","unstructured":"Littman, M. P. Spontaneous systemic hypertension in 24 cats. J. Vet. Intern. Med. 8(2), 79\u201386. https:\/\/doi.org\/10.1111\/j.1939-1676.1994.tb03202.x (1994). PMID: 8046680.","DOI":"10.1111\/j.1939-1676.1994.tb03202.x"},{"key":"71202_CR126","doi-asserted-by":"publisher","unstructured":"Jocelyn, P. C. Spectrophotometric assay of thiols. Methods Enzymol. 143, 44\u201367. https:\/\/doi.org\/10.1016\/0076-6879(87)43013-9 (1987). PMID: 3657559.","DOI":"10.1016\/0076-6879(87)43013-9"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71202-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T02:04:31Z","timestamp":1725501871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71202-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71202"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71202-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4235628\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mochel, Ward, Zannad, Sattar, and Allenspach act as consultants for Ceva Sante Animale. Blondel, Zemirline, and Guillot are employees of Ceva Sante Animale. All other authors do not have a conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20665"}}